Valerio Napolioni

Prof. Valerio Napolioni

School of Biosciences and Veterinary Medicine, University of Camerino, Italy
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Neuron
Verified
Journal Article
Closed access
MBMichaël E. Belloy
Michaël E. Belloy
Valerio NapolioniValerio Napolioni
Valerio Napolioni
MGMichael D. Greicius
Michael D. Greicius

1 August 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CTCatherine Tcheandjieu
Catherine Tcheandjieu
XZXiang Zhu
Xiang Zhu
AHAustin T. Hilliard
Austin T. Hilliard
SCShoa L. Clarke
Shoa L. Clarke
Valerio NapolioniValerio Napolioni
Valerio Napolioni
MPMillion Veteran Program
Million Veteran Program

1 August 2013 in Behavioural Brain Research
Verified
Journal Article
Closed access
APAntonio M. Persico
Antonio M. Persico
Valerio NapolioniValerio Napolioni
Valerio Napolioni

21 November 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
HHHenne Holstege
Henne Holstege
MHMarc Hulsman
Marc Hulsman
CCCamille Charbonnier
Camille Charbonnier
BGBenjamin Grenier-Boley
Benjamin Grenier-Boley
OQOlivier Quenez
Olivier Quenez
JLJean-Charles Lambert
Jean-Charles Lambert
Alzheimer’s disease (AD), the leading cause of dementia, has an estimated heritability of approximately 70%1. The genetic component of AD has been mainly assessed using genome-wide association studies, which do not capture the risk contributed by rare variants2. Here, we compared the gene-based burden of rare damaging variants in exome sequencing data from 32,558 individuals—16,036 AD cases and 16,522 controls. Next to variants inTREM2,SORL1andABCA7, we observed a significant association of rare, predicted damaging variants inATP8B4andABCA1with AD risk, and a suggestive signal inADAM10. Additionally, the rare-variant burden inRIN3, CLU, ZCWPW1andACEhighlighted these genes as potential drivers of respective AD-genome-wide association study loci. Variants associated with the strongest effect on AD risk, in particular loss-of-function variants, are enriched in early-onset AD cases. Our results provide additional evidence for a major role for amyloid-β precursor protein processing, amyloid-β aggregation, lipid metabolism and microglial function in AD.

1 February 2009 in Brain and Development
Verified
Journal Article
Closed access
Valerio NapolioniValerio Napolioni
Valerio Napolioni
RMRomina Moavero
Romina Moavero
PCPaolo Curatolo
Paolo Curatolo

1 March 2013 in Neurotoxicology and Teratology
Verified
Journal Article
Closed access
APAntonio M. Persico
Antonio M. Persico
Valerio NapolioniValerio Napolioni
Valerio Napolioni